Search

everythinglearnresearchcommunity

for

Search:↓

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

DA-9401 helps protect rat testis from finasteride damage.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Dutasteride and finasteride can change hair growth genes, helping treat hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Acne and hidradenitis suppurativa have different causes and risk factors, but both are driven by inflammation and may benefit from treatments targeting interleukin-1.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Injecting hyaluronidase into the artery is effective for treating skin death and hair loss caused by hyaluronic acid fillers.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Acitretin effectively treats severe hypertrophic lichen planus.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Hormonal therapies effectively treat acne and improve quality of life.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Upadacitinib effectively treated severe hair loss in a child.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Topical finasteride may help improve hidradenitis suppurativa symptoms.